DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Nateglinide

Nateglinide

  • Diabetes Medications: Oral Medications

    Diabetes Medications: Oral Medications

  • Orange Book Patent Listing Dispute List

    Orange Book Patent Listing Dispute List

  • Association Between Serious Hypoglycemia and Calcium-Channel Blockers Used Concomitantly with Insulin Secretagogues

    Association Between Serious Hypoglycemia and Calcium-Channel Blockers Used Concomitantly with Insulin Secretagogues

  • Oregon Drug Use Review / Pharmacy & Therapeutics Committee

    Oregon Drug Use Review / Pharmacy & Therapeutics Committee

  • Download Product Insert (PDF)

    Download Product Insert (PDF)

  • Ambetter 90-Day-Maintenance Drug List- 2020

    Ambetter 90-Day-Maintenance Drug List- 2020

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • Medications Used to Treat Type 2 Diabetes

    Medications Used to Treat Type 2 Diabetes

  • Maintenance Drug List Below Is Not Comprehensive and Is Subject to Change Without Prior Notification

    Maintenance Drug List Below Is Not Comprehensive and Is Subject to Change Without Prior Notification

  • The Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus

    The Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus

  • Starlix, INN-Nateglinide

    Starlix, INN-Nateglinide

  • STARLIX (Nateglinide) Tablets, for Oral Use • Common Adverse Reactions Associated with STARLIX (3% Or Greater Initial U.S

    STARLIX (Nateglinide) Tablets, for Oral Use • Common Adverse Reactions Associated with STARLIX (3% Or Greater Initial U.S

  • ACCEPTABLE COMBINATIONS of DIABETES MEDICATIONS (Updated 01/27/2021)

    ACCEPTABLE COMBINATIONS of DIABETES MEDICATIONS (Updated 01/27/2021)

  • Non-Insulin Antidiabetic Agents

    Non-Insulin Antidiabetic Agents

  • Brand Name: Aptiom Generic Name: Eslicarbazepine Manufacturer: Sunovion Pharmaceuticals Inc1 Product Availability: FDA Approved November 2013

    Brand Name: Aptiom Generic Name: Eslicarbazepine Manufacturer: Sunovion Pharmaceuticals Inc1 Product Availability: FDA Approved November 2013

  • Pre-Surgery Diabetes Medications

    Pre-Surgery Diabetes Medications

  • New Drug Evaluation Monograph Template

    New Drug Evaluation Monograph Template

  • A Review of Nateglinide in the Management of Type 2 Diabetes

    A Review of Nateglinide in the Management of Type 2 Diabetes

Top View
  • Starlix, INN-Nateglinide
  • Repaglinide Versus Nateglinide Monotherapy a Randomized, Multicenter Study
  • Package Leaflet: Information for the User Starlix® 60 Mg Film-Coated
  • Cyclohexanes in Drug Discovery
  • Drug Utilization Review Board
  • Diabetes Medications: How They Work
  • Prior Authorization PDL Implementation Schedule
  • Msan(2021)11
  • Brand Generic Guide
  • Non Preferred GLP1 PA
  • Product Monograph Starlix (Nateglinide)
  • Drug Metabolism and Disposition
  • FEP 5 Tier Rx Drug Formulary (607) Standard Option
  • Pharmacological Management of Gestational Diabetes an Overview
  • Differential Interactions of Nateglinide and Repaglinide on the Human -Cell Sulphonylurea Receptor 1
  • Alcohol and Diabetes
  • Nateglinide Improves Early Insulin Secretion and Controls Postprandial Glucose Excursions in a Prediabetic Population
  • Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-The-Counter Medications


© 2024 Docslib.org    Feedback